Valitse sivu
 

BRAIN HEALTH

Sex hormones and the brain: how estrogen and testosterone shape cognitive ergonomics

Tea Latvala 20 July 2026
A focused professional at a desk with a glowing neural network and brain visualization above, depicting how estrogen and testosterone influence cognition.
Introduction

Steroid hormones are not only about reproductive health. Both the female and male central nervous system express estrogen and androgen receptors widely, and estrogen and testosterone directly regulate the brain’s energy use, synaptic connections and stress response.

Drawing on translational neuroscience, this article examines how estradiol and testosterone influence cognitive performance and stress resilience, and why hormonal transitions such as menopause and andropause must be accounted for in the cognitive ergonomics of expert work.

Estrogen as a metabolic and neuroprotective regulator of the brain

Estrogen receptors are densely expressed in brain regions critical for memory, learning and affective regulation, including the hippocampus, amygdala and prefrontal cortex (McEwen & Alves 1999). Estrogen is therefore not a secondary player in the brain but a central regulator of neuronal function and protection.

In the female brain, estradiol is a key regulator of glucose metabolism. It stimulates the pyruvate dehydrogenase enzyme and supports mitochondrial ATP production (Mosconi et al. 2017). With a hormonal transition such as menopause, the decline in ovarian estradiol production exposes the brain to metabolic hypometabolism. This physiological energy crisis correlates directly with the clinically observable brain fog, working memory load and sleep disturbances (Mosconi et al. 2018).

Estrogen is equally vital for male brain health. In male brain tissue, testosterone is converted locally into estradiol via the aromatase enzyme (Balthazart & Ball 2006). This intracerebral estrogen is responsible for synaptic plasticity in the male hippocampus and for protecting neurons against glutamate-induced excitotoxicity. In andropause, the decline in androgen levels therefore reflects directly onto the amount of estradiol available to the brain, which may predispose to a decline in cognitive flexibility.

  • Estradiol stimulates glucose metabolism and mitochondrial ATP production in the brain.
  • In menopause, falling estradiol exposes the brain to hypometabolism, seen as brain fog and working-memory load.
  • In men, testosterone is converted to estradiol in the brain, sustaining synaptic plasticity.

Testosterone as a modulator of motivation, emotional regulation and the HPA axis

Androgen receptors modulate the transcription of the dopamine and serotonin systems in the central nervous system, directly influencing motivational processes, spatial cognition and stress tolerance. Testosterone is thus not merely a hormone of muscle or libido but a central regulator of arousal and load tolerance in the brain.

For men, testosterone acts as a physiological buffer against psychophysical load. Testosterone inhibits the hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis by dampening the secretion of corticotropin-releasing hormone (Viau 2002). With andropause, as serum total testosterone gradually declines, this physiological brake on the axis weakens. Clinically this presents as increased stress sensitivity, physiological fatigue, disturbances of the sleep cycle, and a decline in libido and proactive initiative (Vermeulen 2000).

The female body also physiologically produces significant amounts of androgens in the adrenal cortex and ovaries. In the female central nervous system, testosterone serves as a pro-hormone for estradiol, but it also has direct androgen-receptor-mediated effects. It regulates arousal, prefrontal-mediated attention and amygdala reactivity, which influences libido and emotional flexibility (Davis & Wahlin-Jacobsen 2015). Female androgen levels often begin to decline linearly already in premenopause, which may explain changes in motivation and energy before the onset of the actual estrogen-responsive symptoms.

  • Testosterone dampens HPA-axis hyperactivity and acts as a cortisol buffer.
  • In andropause, falling testosterone weakens the brake on the stress response, seen as fatigue and stress sensitivity.
  • In women, androgens regulate arousal and attention already before menopause.

Conclusions and cognitive ergonomics

When the phenomenon is examined without commercial quick fixes, the translational evidence shows that our cognitive performance and stress resilience are tied to the homeostasis of steroid hormones in the central nervous system. Estradiol acts above all as a regulator of glucoregulation and mitochondrial ATP synthesis, whose deficiency presents as a decline in glucose metabolism, working-memory disturbances and brain fog.

Testosterone, in turn, acts as an inhibitor of the HPA axis, that is, a cortisol buffer, and as a modulator of the dopaminergic system along the mesolimbic pathway. Its deficiency presents as HPA-axis hyperactivity, fatigue, increased stress sensitivity, and a decline in libido and motivation.

When building the cognitive ergonomics of expert work and lifestyle micro-actions such as sleep, recovery and nutrition, it is essential to account for these biological rules. Hormonal transitions require physiology-respecting interventions so that an expert’s performance and brain health can be safeguarded across the lifespan.

  • Estradiol deficiency: decline in glucose metabolism, working-memory disturbances, brain fog.
  • Testosterone deficiency: HPA-axis hyperactivity, fatigue, increased stress sensitivity, decline in libido and motivation.
  • Hormonal transitions require interventions that respect sleep, recovery and nutrition.

Measure, don’t guess.

NeuroAudit™ transforms invisible cognitive load into measurable data. Start your free assessment.

Begin analysis

References & Science

  1. Balthazart J, Ball GF (2006). Is brain aromatase a rapidly regulated enzyme? Frontiers in Neuroendocrinology, 27(3), 273-296. https://doi.org/10.1016/j.yfrne.2006.03.003
  2. Davis SR, Wahlin-Jacobsen S (2015). Testosterone in women: the clinical significance. The Lancet Diabetes & Endocrinology, 3(12), 980-992. https://doi.org/10.1016/S2213-8587(15)00284-3
  3. McEwen BS, Alves SE (1999). Estrogen actions in the central nervous system. Endocrine Reviews, 20(3), 279-307. https://doi.org/10.1210/edrv.20.3.0365
  4. Mosconi L, Berti V, Quinn C et al. (2017). Perimenopause and emergence of an Alzheimer’s bioenergetic phenotype in brain and periphery. PLOS ONE, 12(10), e0185926. https://doi.org/10.1371/journal.pone.0185926
  5. Mosconi L, Rahman A, Diaz I et al. (2018). Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. Neurology, 89(13), 1382-1390. https://doi.org/10.1212/WNL.0000000000004425
  6. Viau V (2002). Functional cross-talk between the hypothalamic-pituitary-adrenal and gonadal axes. Journal of Neuroendocrinology, 14(6), 506-513. https://doi.org/10.1046/j.1365-2826.2002.00798.x
  7. Vermeulen A (2000). Andropause. Maturitas, 34(1), 5-15. https://doi.org/10.1016/S0378-5122(99)00075-4